99 results on '"LOCATELLI, VITTORIO"'
Search Results
2. Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee
3. Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein.
4. Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients
5. Acute and Late Changes in Intraarticular Cytokine Levels Following Anterior Cruciate Ligament Injury
6. Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues
7. Ghrelin expression in gut endocrine growths
8. Hexarelin, but not growth hormone, protects heart from damage induced in vitro by calcium deprivation replenishment
9. Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland
10. miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis.
11. Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues
12. Ghrelin anticonvulsive properties: Is it a matter of desacylation?
13. Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus
14. Neuroendocrine control of growth hormone secretion
15. Ghrelin inhibits inflammatory pain in rats: Involvement of the opioid system
16. GH-related and extra-endocrine actions of GH secretagogues in aging
17. Effects of molsidomine on scopolamine-induced amnesia and hypermotility in the rat
18. Penile erection induced by EP 80661 and other hexarelin peptide analogues: involvement of paraventricular nitric oxide
19. Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury.
20. Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from ventricular dysfunction produced by exposure to calcium-free medium
21. EP 60761 and EP 50885, two hexarelin analogues, induce penile erection in rats
22. miRNA-218 Targets Lipin-1 and Glucose Transporter Type 4 Genes in 3T3-L1 Cells Treated With Lopinavir/Ritonavir.
23. STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages.
24. Intra-Articular Cytokine Levels in Adolescent Patients after Anterior Cruciate Ligament Tear.
25. Neurotrophic and Neuroregenerative Effects of GH/IGF1.
26. JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia.
27. Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells.
28. JMV5656, A Novel Derivative of TLQP-21, Triggers the Activation of a Calcium-Dependent Potassium Outward Current in Microglial Cells.
29. Effects of ACL Reconstructive Surgery on Temporal Variations of Cytokine Levels in Synovial Fluid.
30. Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis.
31. Protective but Not Anticonvulsant Effects of Ghrelin and JMV-1843 in the Pilocarpine Model of Status epilepticus.
32. Central Nervous System-Acting Drugs Influencing Hypothalamic-Pituitary-Adrenal Axis Function.
33. Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice.
34. Low Dose of Insulin for Assessment of Growth Hormone and Cortisol Release in Short Children.
35. Ghrelin Expression and Actions: A Novel Peptide for an Old Cell Type of the Diffuse Endocrine System.
36. Hexarelin Modulates the Expression of Growth Hormone Secretagogue Receptor Type 1a mRNA at Hypothalamic and Pituitary Sites.
37. Ontogeny and Tissue-Specific Regulation of Ghrelin mRNA Expression Suggest that Ghrelin Is Primarily Involved in the Control of Extraendocrine Functions in the Rat.
38. Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: studies in dogs with the use of GH-releasing hormone and a GH-releasing peptide.
39. Contrasting effects of nitric oxide on food intake and GH secretion stimulated by a GH-releasing peptide.
40. Differential Orexigenic Effects of Hexarelin and Its Analogs in the Rat Hypothalamus: Indication for Multiple Growth Hormone Secretagogue Receptor Subtypes.
41. Hexarelin Modulation of MAPK and PI3K/Akt Pathways in Neuro-2A Cells Inhibits Hydrogen Peroxide—Induced Apoptotic Toxicity.
42. Growth Hormone and Hexarelin Prevent Endothelial Vasodilator Dysfunction in Aortic Rings of the Hypophysectomized Rat.
43. Pituitary Hormones and Ergot Alkaloids.
44. Release of Growth Hormone by TRH in Intact Rats or in Intact or Hypophysectomized Rats bearing a Heterotopic Pituitary.
45. Effect of Enhancement of Cholinergic Tone on the Growth Hormone Response to Acute Hyperglycaemia or Thyrotropin-Releasing Hormone in Dogs.
46. Functional Interrelationships Between Adrenergic and Opioid Systems in the Neuroregulation of Growth Hormone Secretion in Infant Rats.
47. Continuous subtherapeutic insulin counteracts hypothalamopituitary-gonadal alterations in diabetic rats.
48. Hexarelin Stimulation of Growth Hormone Release and mRNA Levels in an Infant and Adult Rat Model of Impaired GHRH Function.
49. Mechanism of Action of Hexarelin and GHRP-6: Analysis of the Involvement of GHRH and Somatostatin in the Rat.
50. Combined Administration of Growth-Hormone-Releasing Hormone and Clonidine Restores Defective Growth Hormone Secretion in Old Dogs.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.